ADI
47
2
ROST
52
5
MLM
51
3
AMZN
55
-3
EXPE
91
3
BAX
30
4
SLG
66
2
CVX
44
-2
RL
68
3
NWS
69
7
JPM
67
4
EXC
56
2
CMI
64
5
FMC
33
2
RHI
57
3
VTR
54
5
SWK
61
5
XRX
41
6
SIG
49
6
STI
31
-16
ADI
47
2
ROST
52
5
MLM
51
3
AMZN
55
-3
EXPE
91
3
BAX
30
4
SLG
66
2
CVX
44
-2
RL
68
3
NWS
69
7
JPM
67
4
EXC
56
2
CMI
64
5
FMC
33
2
RHI
57
3
VTR
54
5
SWK
61
5
XRX
41
6
SIG
49
6
STI
31
-16
Financhill
Back

DuPont de Nemours 10K Form

Buy
60

DD
DuPont de Nemours

Last Price:
83.29
Seasonality Move:
2.75%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DD News And Ratings

See the #1 stock for the next 7 days that we like better than DD

DD Financial Statistics

Sales & Book Value

Annual Sales: $12.07B
Cash Flow: $309M
Price / Cash Flow: 28.27
Annual Sales: $57.94
Price / Book: 1.43

Profitability

EPS (TTM): 1.90000
Net Income (TTM): $799M
Gross Margin: $4.23B
Return on Equity: 3.28%
Return on Assets: 2.11%

DuPont de Nemours Earnings Forecast

Key DuPont de Nemours Financial Ratios

  • The Gross Profit Margin over the past 40 years for DD is 35.08%.
  • The Selling, General & Administrative Expenses for DD have been equal to 11.74% of Gross Profit Margin.
  • The Research & Development expenses have been 4.21% of Revenue.
  • The Interest Expense is 93.62% of Operating Income.
  • The Net Earning history of DD is 3.51% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 20 years.

DuPont de Nemours Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Chemicals
Sector: Materials
Current Symbol: DD
CUSIP: 26614N
Website: dupont.com

Debt

Debt-to-Equity Ratio: 0.29
Current Ratio: 2.28
Quick Ratio: 1.42

Price-to-Earnings

Trailing P/E Ratio: 88.03
Forward P/E Ratio: 18.82

DD Technical Analysis vs Fundamental Analysis

Buy
60
DuPont de Nemours (DD) is a Buy

Is DuPont de Nemours a Buy or a Sell?

  • DuPont de Nemours stock is rated a Buy
    The current DuPont de Nemours [DD] share price is $82.75. The Score for DD is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.